Ifp Advisors, Inc G1 Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

9 transactions

Quarter	Operation	Price Per share	shares change
Q3 2021 Oct 06, 2021	SELL	$13.16 - $22.47 $0 - $0	0 Closed
Q2 2021 Jul 13, 2021	BUY	$19.57 - $26.32 $0 - $0	0 New
Q1 2021 Apr 30, 2021	BUY	$17.58 - $32.59 $0 - $0	0 New
Q4 2020 Jan 25, 2021	BUY	$10.99 - $20.4 $0 - $0	0 New
Q3 2020 Oct 29, 2020	BUY	$11.55 - $23.75 $0 - $0	0 New
Q2 2020 Aug 05, 2020	BUY	$9.57 - $24.37 $0 - $0	0 New
Q1 2020 May 12, 2020	BUY	$9.07 - $26.32 $0 - $0	0 New
Q4 2019 Jan 17, 2020	BUY	$20.54 - $31.0 $0 - $0	0 New
Q3 2019 Nov 07, 2019	BUY	$22.78 - $40.58 $0 - $0	0 New

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.